Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

The new nanoparticles could improve melanoma treatment by working better than current options.

ZD1839 (Iressa) causes skin and hair side effects, treatable with tretinoin cream and minocycline.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Deucravacitinib helped a man regrow hair significantly.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Posaconazole is a promising new treatment for toenail fungus.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Combined BRAF and MEK treatment increases rash risk but reduces other skin issues compared to BRAF alone.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

Tofacitinib may help treat severe hair loss, but more research is needed.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Baricitinib improved hair loss and arthritis in a lupus patient.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.